More Time, More Research, More Hope: Double your Impact!

29 November 2022 In Allies & Partnerships, Events, News

To share their gratitude for all those who are making a difference in melanoma research, our founders — Debra & Leon Black — are matching all gifts* to MRA up to $1 MILLION this holiday season. Donate Today!

Read More

Artificial Intelligence & Melanoma Detection: Closing the Gaps

15 November 2022

The earlier a cancer is detected, the better the patient’s prognosis. However, detecting melanoma isn't always clear cut. We currently identify melanoma based on subjective visual criteria and accuracy varies greatly from practitioner to practitioner and clinic to clinic. Artificial intelligence has the potential to improve this, but isn't quite ready for primetime.

Read More

From Melanoma Patient to Caregiver

By Renee Orcione, MRA Development Associate | 11 November 2022

By the time she was 26-years old, Leah Adams had spent countless hours tanning. Growing up in Ohio where the winters were long, she felt a pressure to stay tan far beyond the summer months, so she turned to tanning beds.

Read More

The Changing Melanoma Landscape

7 November 2022

Before 2011, the melanoma treatment arena was in a sustained drought during which patients were only offered a few treatments, and few with advanced stages of the cancer were still alive a year after starting treatment.

Read More

Facing Melanoma Together: Kate O'Neil

31 October 2022

Prior to the creation of modern melanoma therapies, Kate O'Neil's sister Noreen was diagnosed, treated, and ultimately passed away from the disease. To honor her sister's legacy, Kate has become a champion of melanoma research.

Read More

FDA Approves Opzulera for At-Home Therapy for Skin Repigmentation: What this Means for Melanoma Patients with Vitiligo

By Isabel Ryan, MRA Intern | 24 October 2022 In News, Science

On July 18th, the U.S. Food & Drug Administration (FDA) approved the first topically-applied treatment for skin repigmentation for patients with vitiligo after strong results from two Phase 3 trials. Vitiligo, a chronic skin disease, affects 3 in 100 people who have melanoma, categorized as melanoma-associated vitiligo. The approval invites patients with vitiligo, including those with melanoma, to talk with their providers on how Opzelura can serve their skin needs.

Read More

Music vs. Melanoma: 13-Year-Old Raises $6K for Research

By Renee Orcione, MRA Development Associate | 7 October 2022

Cassidy Battin, an 8th grader from Carlsbad, California, and her family are no strangers to melanoma. Her great aunt sadly died of uveal melanoma, a rare subtype that forms in the eye, when Cassidy was younger. Her grandfather also had melanoma, along with several other loved ones in the family.

Read More

Fish & Melanoma: What’s the Connection?

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 4 October 2022 In News

A study led by researchers at Brown University surprisingly found that people who ate the most fish were the most likely to develop melanoma. Before you change your diet, read more about the study, its findings, and limitations.

Read More

Mollie’s Fund Partners to Prevent Skin Cancers Among Firefighters

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 8 September 2022 In Prevention

Every day firefighters put their own safety on the line to protect the lives and property of others. It’s a tough job that puts those who do it at increased risk for burns, smoke inhalation, and other injuries.

Read More

Overcoming Melanoma Treatment Resistance Research Update

24 August 2022 In Science, Treatment

About half of all patients given cancer immunotherapies do not respond to them, and although targeted therapies often dramatically shrink tumors in most patients, in about three-quarters of those patients, the treatments stop being effective weeks to months after initially killing tumor cells.

Read More